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Abstract
Virulence of Clostridium difficile is primarily attributed to the large clostridial toxins A and B
while the role of binary toxin (CDT) remains unclear. The prevalence of human strains of C.
difficile possessing only CDT genes (A−B−CDT+) is generally low (< 5%), however, this
genotype is commonly found in neonatal livestock both in Australia and elsewhere. Zoonotic
transmission of C. difficile has been suggested previously. Most human diagnostic tests will
not detect A−B−CDT+ strains of C. difficile because they focus on detection of toxin A and/or
B. We performed a prospective investigation into the prevalence and genetic characteristics
of A−B−CDT+ C. difficile in symptomatic humans. All glutamate dehydrogenase or toxin B
gene positive faecal specimens from symptomatic inpatients over 30 days (n = 43) were
cultured by enrichment, and C. difficile PCR ribotypes (RTs) and toxin gene profiles deter-
mined. From 39 culture-positive specimens, 43 C. difficile isolates were recovered, including
two A−B−CDT+ isolates. This corresponded to an A−B−CDT+ prevalence of 2/35 (5.7%) iso-
lates possessing at least one toxin, 2/10 (20%) A−B− isolates, 2/3 CDT+ isolates and 1/28
(3.6%) presumed true CDI cases. No link to Australian livestock-associated C. difficile was
found. Neither A−B−CDT+ isolate was the predominant A−B−CDT+ strain found in Australia,
RT 033, nor did they belong to toxinotype XI. Previous reports infrequently describe A−B−CDT+
C. difficile in patients and strain collections but the prevalence of human A−B−CDT+ C. difficile
is rarely investigated. This study highlights the occurrence of A−B−CDT+ strains of C. difficile in
symptomatic patients, warranting further investigations of its role in human infection.
Introduction
Clostridium difficile is an anaerobic, spore-forming gram positive bacillus and a major cause of
antibiotic associated life-threatening diarrhoea in humans and animals, particularly pigs. C.
difficile infection (CDI) is the most common healthcare-associated infection in the United
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States [1]. The classical virulence factors of C. difficile are the glycosylating large clostridial tox-
ins (LCTs), toxins A and B. These are encoded by the genes tcdA and tcdB, respectively, located
on the LCT pathogenicity locus (PaLoc) [2]. A third toxin, known as C. difficile binary toxin
(CDT), is an actin-specific ADP-ribosyltransferase encoded on a separate pathogenicity island
(CdtLoc) [3]. The exact role of CDT in CDI remains unclear. Instances of human infection
involving strains of C. difficile producing only CDT (A−B−CDT+) are infrequent [4–9], yet such
strains are often found in animals [10–12]. C. difficile PCR ribotype (RT) 033 (A−B−CDT+) is
the 2nd most prevalent RT in Australian veal calves and piglets [10, 13] while in German calves
62% of isolates were RT 033 or a similar A−B−CDT+ strain, RT 288 [11].
Zoonotic transmission of C. difficile from animals via food and/or the environment is
suggested by overlaps in RTs of C. difficile found in humans and animals. In Europe and the
USA, a virulent lineage of C. difficile (RT 078) is commonly found in both [14]. The disparity
between the prevalence of A−B−CDT+ C. difficile in humans and animals may be due to differ-
ences in methods used for detecting C. difficile. Human diagnostic laboratories focus on detec-
tion of the LCT genes or proteins by nucleic acid amplification or enzyme immunoassay,
respectively, while animal studies generally use culture [10–13, 15] due to the poor perfor-
mance of human diagnostic tests with animal samples [16]. Prior to this study, we had 23 Aus-
tralian human A−B−CDT+ isolates in our collection, 11 of which (47.8%) were RT 033 (S1
Table), a RT commonly seen in neonatal Australian livestock [10, 13, 15]. This prompted us to
investigate the prevalence and molecular epidemiology of human CDI potentially caused by
A−B−CDT+ C. difficile that would otherwise go undetected by conventional diagnostic testing.
Materials and methods
Study design
All faecal specimens collected between (and including) 2014/12/31 to 2015/01/29 (30 days)
from two of five tertiary public hospitals in Perth, Western Australia (WA), all other public
hospitals in the state and certain private laboratories were used for this study. Specimens were
submitted as part of routine microbiological investigation, which included specific or reflexive
testing for C. difficile. Each source referred all their routine C. difficile testing to PathWest Lab-
oratory Medicine, the single public sector pathology service provider for WA. The combined
bed capacity of all hospitals in the study was ~3700. Specimens from these referring locations
were estimated to account for ~65% of all public C. difficile testing performed in the state of
WA.
All patients included were symptomatic inpatients over 2 years old who had not submitted
a stool for CDI testing for more than 8 weeks preceding the study period; thus all CDI cases
were considered new [17]. Most samples were also routinely tested for the presence of the
enteric pathogens Salmonella, Shigella and Campylobacter. Cases without these organisms but
with C. difficile possessing at least one toxin gene (A, B or CDT) were assumed to be true cases
of CDI. If these organisms were detected or only C. difficile with no toxin genes was recovered,
then the case was assumed not to be CDI for the purposes of this study. If testing had not been
performed for these organisms, the case was considered indeterminate.
Routine diagnostic C. difficile testing used the BD MAX™ Cdiff assay (BD Diagnostics), a
real-time PCR that detects the tcdB gene. Only the earliest BD MAX positive specimen from
each patient was collected. If no positive specimen existed, the earliest BD MAX negative speci-
men was used instead such that each patient was represented by one sample. BD MAX nega-
tive samples were screened for glutamate dehydrogenase (GDH), a cell wall enzyme common
to all strains of C. difficile regardless of toxin production [18], using the TechLab1 CHEK™-60
(TechLab) in accordance with the manufacturer’s instructions.
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PLOS ONE | https://doi.org/10.1371/journal.pone.0187658 November 8, 2017 2 / 10
following competing interests: Professor Riley
received non-financial support from Alere during
the conduct of the study and has received grants
from Cepheid, MSD and Otsuka outside the
submitted work. This does not alter our adherence
to PLOS ONE policies on sharing data and
materials.
Identification and isolation of C. difficile
BD MAX or GDH positive stool samples were inoculated into enrichment broth containing
gentamicin (5 mg/L), cycloserine (200 mg/L) and cefoxitin (10 mg/L) supplemented with 0.1%
(w/v) sodium taurocholate. After 48 h of incubation, inoculated broths were mixed with an
equal volume of absolute ethanol and left at room temperature for 60 min before an aliquot
was plated onto chromID™ C. difficile agar (bioMe´rieux). Incubation of agar plates and identifi-
cation of C. difficile was performed as previously described [10]. Co-infection with multiple C.
difficile RTs was analysed by subculturing and PCR ribotyping up to six randomly selected col-
onies per sample, with priority given to colonies of varying morphology.
Molecular characterisation of C. difficile
PCR ribotyping and detection of tcdA, tcdB, the CDT enzymatic component gene (cdtA) and
CDT binding component gene (cdtB) were performed as previously described [10] with slight
modification. The novel primers BE-tcdA-1 (Forward: 50-CAGTCACTGGATGGAGAATT-30)
and BE-tcdA-2 (Reverse: 50-AAGGCAATAGCGGTATCAG-30) specific for the 3’ end of tcdA
(tcdA3) were multiplexed with the NK2 and NK3 primers specific for the 5’ end of tcdA (tcdA1)
[19]. Reaction mixes (total volume 20 μL) consisted of 4 μL of DNA extract, 10 mM Tris-HCl
(pH 8.3) and 50 mM KCl, 1.5 mM MgCl2, 0.2 μM of each primer, 200 μM of each dNTP, 1.25
U AmpliTaq Gold1 DNA polymerase and 0.1 mg/mL BSA. Reactions were run with an initial
denaturation step of 95 oC for 10 min, followed by 35 cycles of 94 oC for 30 s, 55 oC for 30 s
and 72 oC for 90 s, with a final extension step of 72 oC for 7 min. Detection of both tcdA1 and
tcdA3 fragments was required for an isolate to be considered tcdA positive.
Identification of RTs was achieved using the BioNumerics (v7.5, Applied Maths) software
package to compare banding patterns with our reference library consisting of 74 reference
strains from the UK Clostridium difficile ribotyping network (CDRN) and various Australian
RTs. Isolates that could not be matched with any reference collection strain were designated
with our internal RT prefix “QX”.
For whole genome sequencing (WGS), genomic DNA was extracted from a 48 h blood agar
subculture of C. difficile using the QuickGene Mini80 and QuickGene DNA tissue kit (Kurabo
Industries) in conjunction with an MPBio FastPrep-24™ 5G (MP Biomedicals) at a speed of 6
m/s for 40 s. Multiplexed paired-end libraries were generated using the KAPA Hyper Prep
(KAPA Biosystems). Pooled genomic libraries were sequenced on a MiSeq platform (illumina).
Sequence data (trimmed fastq files) have been deposited in the European Nucleotide Archive
under study PRJEB19597 (accession ERS1566888–ERS1566897).
Genomes were assembled de novo and annotated as previously described [20]. Multilocus
sequence type (MLST, ST) was determined in silico from assembled contigs using the scheme
of Griffiths et al. [21]. The presence of toxin genes was determined in silico by generating
whole genome alignments in Mauve v2.4.0 [22] against C. difficile reference strain M120 (Gen-
Bank accession FN665653). High resolution single nucleotide variant (SNV) analysis was per-
formed on the non-repetitive non-recombinant core genome as previously described [20].
Ethics statement
As this study used biospecimens that were obtained for clinical purposes and stored by an
accredited pathology laboratory no specific human research ethics approval was required
under the guidelines set out in the Australian National Health and Medical Research Council
(NH&MRC) National Statement on Ethical Conduct in Human Research. Any patient infor-
mation had been sufficiently anonymised so that neither the patients nor anyone else could
identify the patients with certainty.
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Results
Sample collection, isolation and identification of C. difficile
A sample collection and isolation summary is shown in Fig 1. The number of BD MAX or
GDH positive samples was 43 (7.3%) from 592 samples. In total, 43 isolates of C. difficile were
recovered from 39 samples. Of the 39 C. difficile positive patients, 28 (71.8%) were presumed
as CDI, eight (20.5%) as non-CDI and three (7.7%) as indeterminate. Of the 28 patients with
CDI, 27 (96.4%) were considered to be ‘typical’ (tcdB positive) CDI episodes, with the one
remaining case being only CDT positive (3.6%).
Prevalence and molecular characteristics
Five distinct toxin profiles were identified; the majority of isolates were A+B+CDT− (n = 31,
72.1%) followed by non-toxigenic (A−B−CDT−) (n = 8, 18.6%), A−B−CDT+ (n = 2, 4.7%),
A−B+CDT− (n = 1, 2.3%) and A+B+CDT+ (n = 1, 2.3%) strains. Most RTs possessing at least
one toxin were RT 014/020 (n = 12, 34.3%) followed by RT 012 (n = 3, 8.6%) (Table 1). No RT
027 or RT 078 isolates were recovered. The prevalence of CDT+ and A−B−CDT+ isolates
amongst isolates possessing at least one toxin was 8.6% and 5.7%, respectively (Table 1).
A−B−CDT+ isolates comprised two of three CDT+ isolates recovered and 20% of A−B− isolates
(Table 1).
Of the three patients with CDT+ isolates, two were considered to be true cases of CDI. This
included one patient with a specimen positive only for A+B+CDT+ C. difficile (QX 480) and
another patient with an A−B−CDT+ (QX 625) and A−B−CDT− (QX 531) C. difficile co-infec-
tion. The third patient with A−B−CDT+ C. difficile (QX 626) was also positive for A−B−CDT−
(RT 051) and A+B+CDT− C. difficile (RT 020) but not considered a CDI case due to the concur-
rent isolation of Salmonella Typhimurium. None of the CDT+ RTs was a known livestock-
Fig 1. Flowchart of sample collection and isolation. Process flowchart and count of sample collection and Clostridium difficile isolation. BD
MAX, BD MAX™Cdiff assay (BD diagnostics); GDH, glutamate dehydrogenase.
https://doi.org/10.1371/journal.pone.0187658.g001
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associated Australian strain nor could they be matched to our collection of international refer-
ence strains. Interestingly, both patients with A−B−CDT+ isolates (AM 0014 and AM 0021)
were admitted to the same remote hospital at least 3 days apart. Additionally, the 3’ end of
tcdA was not detected by PCR in either A−B−CDT+ isolate (Table 1), suggesting they did not
belong to toxinotype XI.
The apparent lack of a tcdA 3’ fragment, unique RTs and epidemiological clustering of AM
0014 and AM 0021 prompted us to investigate further using WGS. The absence of the entire
PaLoc and presence of the complete CdtLoc were confirmed in silico for both isolates. Neither
isolate belonged to previously known STs, but were single loci variants of various clade 5 line-
ages. They were given the new ST numbers, ST 392 and 387, respectively (Table 2). SNV analy-
sis conclusively showed that despite epidemiological clustering AM 0014 and AM 0021 were
genetically distinct from each other (2104 SNVs) and from 7 other non-toxinotype XI
A−B−CDT+ strains in our collection (Table 2).
Discussion
Due to previous isolations of suspected Australian livestock-associated A−B−CDT+ C. difficile
in symptomatic patients, we investigated the prevalence of these strains in human CDI,
Table 1. Ribotype distribution of study isolates.
PCR
Ribotype
Toxin PCR result PCR Toxin
Profile
n % Ribotypes
(all)
% Ribotypes ( 1
toxin)
% Ribotypes
(CDT+)
% Ribotypes
(A−B−)tcdA1 tcdA3 tcdB cdtA cdtB
1 RT 014/020 + + + − − A+B+CDT− 12 27.9 34.3
2 RT 012 + + + − − A+B+CDT− 3 6.98 8.57
3 RT 015 + + + − − A+B+CDT− 2 4.65 5.71
4 RT 056 + + + − − A+B+CDT− 2 4.65 5.71
5 RT 081 + + + − − A+B+CDT− 2 4.65 5.71
6 QX 076 + + + − − A+B+CDT− 2 4.65 5.71
7 RT 001 + + + − − A+B+CDT− 1 2.33 2.86
8 RT 002 + + + − − A+B+CDT− 1 2.33 2.86
9 RT 049 + + + − − A+B+CDT− 1 2.33 2.86
10 RT 053 + + + − − A+B+CDT− 1 2.33 2.86
11 RT 103 + + + − − A+B+CDT− 1 2.33 2.86
12 RT 137 + + + − − A+B+CDT− 1 2.33 2.86
13 QX 001 + + + − − A+B+CDT− 1 2.33 2.86
14 QX 087 + + + − − A+B+CDT− 1 2.33 2.86
15 RT 017 + − + − − A−B+CDT− 1 2.33 2.86
16 QX 480 + + + + + A+B+CDT+ 1 2.33 2.86 33.3
17 QX 625* − − − + + A−B−CDT+ 1 2.33 2.86 33.3 10
18 QX 626* − − − + + A−B−CDT+ 1 2.33 2.86 33.3 10
19 RT 010 − − − − − A−B−CDT− 2 4.65 20
20 RT 051 − − − − − A−B−CDT− 2 4.65 20
21 RT 009 − − − − − A−B−CDT− 1 2.33 10
22 QX 012 − − − − − A−B−CDT− 1 2.33 10
23 QX 121 − − − − − A−B−CDT− 1 2.33 10
24 QX 531* − − − − − A−B−CDT− 1 2.33 10
Total, n (%) 43 43 (100%) 35 (100%) 3 (100%) 10 (100%)
tcdA1, toxin A gene 5’ fragment; tcdA3, toxin A gene 3’ fragment
*new ribotype
https://doi.org/10.1371/journal.pone.0187658.t001
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isolating two human A−B−CDT+ C. difficile strains from 592 faecal samples. Neither isolate was
related to the predominant Australian A−B−CDT+ strain of C. difficile, RT 033, nor were they
known to be livestock-associated. Our overall C. difficile positive rate and RT distribution was
similar to that seen previously [23]. Epidemic RTs 027 and 078 were not detected, reflecting
the continuing rarity of these RTs in Australia.
Despite recent and increasingly frequent reports of A−B−CDT+ C. difficile in humans and
animals [5–9, 11, 12, 24], the prevalence of these strains in humans is seldom investigated and
reports are sporadic [4–9]. Reviews of strain collections, comprising strains from diverse
sources collected over many years, indicate that the prevalence of A−B−CDT+ C. difficile in
humans is generally low (< 5%) [4, 8]. A recent study estimated the prevalence of A−B−CDT+
C. difficile by retrospectively screening 220 A−B− consecutively obtained isolates for CDT [5].
These isolates were accumulated from two French metropolitan hospitals over nearly 2 years
and Eckert et al. [5] recovered one A−B−CDT+ RT 033-like isolate belonging to toxinotype
XIb, a prevalence of 0.45% amongst A−B− isolates. Our prevalence of A−B−CDT+ C. difficile
amongst A−B− isolates was much higher (20%) and observed over a significantly shorter time-
frame than Eckert et al. [5]. The small sample size of our study, differences in methodology
and geographic variation may explain this difference.
PaLoc positive C. difficile RTs can belong to one of 34 PCR-restriction fragment length
polymorphism groups known as toxinotypes [25]. RTs 033 and 288 belong to toxinotype XI,
which does not produce the LCTs due to a large deletion leaving only the 3’ end of tcdA [25].
Both RT 033 and 288 are ST11 placing them within clade 5 [21]. Of these RTs, RT 033 appears
to be the predominant A−B−CDT+ strain in circulation with other toxinotype XI RTs, RT 153
and SLO 187, rarely reported [24, 25]. The absence of RT 033 C. difficile in our study was not
wholly unexpected as nine of 11 (81.8%) previous RT 033 human cases were from outside WA
(S1 Table). Additionally, we had previously only isolated RT 033 and RT 288 in Australian ani-
mal populations outside WA [10, 13, 15].
All A−B−CDT+ C. difficile recovered in this study were non-toxinotype XI. Non-toxinotype
XI A−B−CDT+ strains are extremely rare; to our knowledge only seven have been described [4,
6]. We previously reported human and animal non-toxinotype XI, A−B−CDT+ C. difficile in
WA [6], yet the A−B−CDT+ RTs encountered in this study were novel. The great heterogeneity
of these strains (Table 2) suggests a diverse population of such strains locally. The molecular
epidemiology of CDI in Australia appears unique, evidenced by the presence of seemingly
exclusive RTs and a diverse population of clade 5 strains [6]. This means our observations may
be peculiar to Australia. Conversely, these strains may be distributed globally but remain
uncharacterised due to limited adoption of appropriate detection methods in routine surveil-
lance. Recently, diagnostic testing methods have been increasingly incorporating CDT detec-
tion [26], usually in order to presumptively identify the A+B+CDT+ RT 027. These tests have
the added benefit of potentially detecting A−B−CDT+ C. difficile. However, as a reflection of
the unclear role CDT plays in disease, these tests rarely report CDT specifically and, until
recently, did not report A−B−CDT+ results unless prompted to [26].
Both patients with A−B−CDT+ C. difficile harboured multiple strains of C. difficile and, in
one case, Salmonella Typhimurium, possibly suggesting infection from a microbiologically
diverse source, such as the environment or food. Community-associated CDI (CA-CDI) is
understudied in general and A−B−CDT+ C. difficile strains are likely to be missed. Additionally,
the non-toxigenic C. difficile present in both our patients may have competed against toxin-
producing C. difficile, protecting the patient in the process [27]. The significance of co-infec-
tion in this study and CDI in general remains unclear. Most cases of CDI appear monoclonal
in origin with the prevalence of co-infection suggested to be ~10% [28–31]. The simultaneous
presence of multiple C. difficile RTs might indicate an early stage of infection, with one RT yet
Prevalence of binary toxin positive C. difficile
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to dominate others. We could not assess the relative quantities of each co-infecting strain due
to our use of enrichment culture. Additionally, it would have been ideal to pick more than 6
colonies from each plate.
An alternative explanation for the low prevalence of animal-associated A−B−CDT+ strains
of C. difficile in humans may be the transient lifecycle of C. difficile within reservoirs like calves
and piglets [10–13]. The prevalence of C. difficile within these populations rapidly diminishes
after three weeks of age [11, 32] unless animals are given antimicrobials directly, or indirectly
via the mother. These reservoirs have little link to the general human population beside the
slaughter of very young calves and suckling pigs for human consumption, both of which are
not widely practised in Australia.
The mild effect of A−B−CDT+ C. difficile seen recently in hamster and mouse models of
infection [33, 34] highlights the need to conclusively prove any epidemiological association
between A−B−CDT+ C. difficile and disease. Such investigations should not be limited to
humans, nor should they be limited to symptomatic patients, as asymptomatic patients could
also harbour such strains. Future studies will need to comprehensively exclude all alternative
causes of CDI symptoms and ideally show symptom resolution due to C. difficile specific
treatment.
To summarise, in a sample of 592 faecal specimens, LCT-negative, binary toxin-positive C.
difficile comprised two of three binary toxin positive human isolates and ~4% of presumed
true CDI cases. No link to Australian livestock-associated A−B−CDT+ C. difficile was estab-
lished. This study highlights the presence of these strains in symptomatic humans and suggests
a diverse population of such strains locally. Larger prevalence surveys and surveillance of ani-
mal populations are essential to clarify the relationship between A−B−CDT+ C. difficile and
their human and animal hosts.
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